期刊文献+

单纯腹腔细胞学阳性子宫内膜癌Ⅲa期患者的预后 被引量:2

Different prognosis of patients with stage Ⅲa endometrial carcinoma
下载PDF
导出
摘要 目的 研究不同子宫内膜癌Ⅲa期患者的预后 ,为临床治疗提供依据。方法 对 1988~ 2 0 0 1年在我院收治的子宫内膜癌Ⅰ期、Ⅲ期患者共 191例进行回顾性分析。患者共分为四组 :第一组为Ⅰ期患者 ,共134例 ;第二组为单纯腹腔细胞学阳性的子宫内膜癌Ⅲa期患者 ,共 2 3例 ;第三组为伴有浆膜浸润或附件转移的子宫内膜癌Ⅲa期患者 ,共 16例 ;第四组为子宫内膜癌Ⅲb期 +Ⅲc期患者 ,共 18例。采用Kaplan -Meier法对四组的平均生存时间进行计算 ,并进行比较。结果 ①第一组与第二组的平均生存时间差异无显著性 ,P >0 0 5 ;②第二组与第三组的平均生存时间差异有明显统计学意义 ,P <0 0 1;③第三组与第四组的平均生存时间差异无显著性 ,P >0 0 5。结论 尽管腹腔细胞学阳性、浆膜浸润及附件转移均被定为子宫内膜癌Ⅲa期 ,但单纯腹腔细胞学阳性的患者其预后明显好于伴有浆膜层浸润或附件转移者。 Objective To investigate the different prognosis of patients with different stage Ⅲa endometrial carcinoma,i e positive peritoneal cytology, or(with)invasion of uterine serosa and adnexa metastasis Methods The clinicopathological data of the patients with stage Ⅰ and stage Ⅲ endometrial carcinoma treated in our hospital from 1988 to 2001 were analyzed retrospectively One hundred and ninety-one patients were divided into four groups,group 1(n=134) stage Ⅰ patients,group 2 (n=23) Ⅲa with positive peritoneal cytology alone,group 3 (n=16) Ⅲa with invasion of uterine serosa or adnexa metastasis,group 4 (n=18)Ⅲb and Ⅲc The mean survival time of the four groups was calculated with Kaplan-Meier method and COX regression was used to study the relative risk factors Results There was no difference of the mean survival time between group 1 and 2,neither does that between group 3 and 4,while there was statistical difference between group 2 and 3( P <0 01) Conclusions The prognosis of the stage Ⅲa patients with only positive peritoneal cytology is much better than other Ⅲa patients They should be treated differently
出处 《中国妇产科临床杂志》 2003年第1期31-33,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 子宫内膜肿瘤 腹腔细胞学 预后 Endometrial neoplasm Peritoneal cytology Prognosis
  • 相关文献

参考文献7

  • 1[1]连利娟,主编.林巧稚妇科肿瘤学.第3版.北京:人民卫生出版社,1999.425-440.
  • 2[2]Arikan G, Reich O, Weiss U, et al. Are endometrial carcinoma cells disseminated at hysteroscopy functionally viable? Gynecol Oncol, 2001 , 83: 221 - 226
  • 3[3]Obermir A, Geramou M, Tripcony L, et al. Peritoneal cytology: im pact on disease - free survival in clinical stage I endometrioid adenocarci noma of the uterus. CancerLett, 2001 , 164:105-110
  • 4[4]YanohK, TakeshimaN, HirariY, et al.lndentification of a high - risk subgroup in cytology - positive stage ⅢA endometrial cancer. Acta Cytol, 2001, 45:691-696
  • 5[5]Hirai Y, Takeshima N, Kato T, et al. Malignant potential of positive peritoneal cytology in endometrial cancer. Obstet Gynecol, 2001, 97 (5Pt1): 725 - 728
  • 6[6]Mariani A, Webb MJ, Keeney GL, et al. Assessment of prognostic factors in stage ⅢA endometrial cancer. Gynecol Oncol , 2002, 86:38 - 44
  • 7[7]Ebina Y, Hareyama H, Sakuragh N, et al. Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg, 1997, 82: 244- 248

共引文献1

同被引文献13

  • 1Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010.CA Cancer J Clin,2010,60:277-300.
  • 2Pecorelli S.Revised FIGO staging for carcinoma of the vulva,cervix,and endometrium.Int J Gynaecol Obstet,2009,105:103-104.
  • 3Welander C,Griem ML,Newton M,et al.Staging and treatment of endometrial carcinoma.J Reprod Med,1972,8:41-46.
  • 4Creasman WT,Eddy GL.Recent advances in endometrial cancer.Semin Surg Oncol,1990,6:339-342.
  • 5Lewin SN,Herzog TJ,Barrena Medel NI,et al.Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer.Obstet Gyneco1,2010,116:1141-1149.
  • 6Morrow CP,Bundy BN,Kurman R J,et al.Relationship between surgical-pathological risk factors and outcome in clinical stage Ⅰ and Ⅱ carcinoma of the endometrium:a Gynecologic Oncology Group study.Gynecol Onco1,1991,40:55-65.
  • 7NCCN clinical practice guidelines in oncology.Uterine neoplasms.V.1.2010[EB/OL] .[2011407-10] .http://www.nccn.org/index.asp.
  • 8Sato S,Itamochi H,Shimada M,et al.Preoperative and intraoperative assessments of depth of myometrial invasion in endometrial cancer.Int J Gynecol Cancer,2009,19:884-887.
  • 9Ozdemir S,Celik C,Emlik D,et al.Assessment of myometrial invasion in endometrial cancer by transvaginal sonography,Doppler ultrasonography,magnetic resonance imaging and frozen section.Int J Gyneeol Cancer,2009,19:1085-1090.
  • 10NCCN clinical practice guidelines in oncology:uterine neoplasms.V.1.2011[EB/OL] .[2011-07-10] .http://www.nccn.org/index.asp.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部